About admin

This author has not yet filled in any details.
So far admin has created 14 blog entries.

Dr Rodrigo Dienstmann, VHIO presents COLOSSUS at the AACR

2018-10-03T10:24:25+00:00October 3rd, 2018|

Dr Rodrigo Dienstmann of Vall d'Hebron University Hospital, Barcelona, Spain presented COLOSSUS at the American Association for Cancer Research (AACR) Intestinal Stem Cells and Colon Cancer: Biology to Therapy conference. The four-day meeting ran from the 27-30 September 2018 in Washington, DC, USA. Rodrigo's talk, "Risk stratification as a basis for targeted therapy in colon [...]

Darran O’ Connor, RCSI presents COLOSSUS findings at 2018 ASCO

2018-09-28T09:59:25+00:00September 28th, 2018|

A study: 'SATB2 loss and the immune milieu of colorectal cancer (CRC)'  was presented by Dr Darran O' Connor, a cancer biologist at the Royal College of Surgeons Ireland at the Gastrointestinal (Colorectal) Cancer session at the 2018 American Society of Clinical Oncology (ASCO) Annual Meeting. Findings conclude that SATB2 acts as a master regulator of inflammation [...]

Florent Petitprez, INSERM, presents COLOSSUS studies at ESMO’s MAP 2018

2018-09-24T16:04:33+00:00September 24th, 2018|

COLOSSUS researcher Florent Petitprez, of INSERM, presented COLOSSUS studies at The European Society of Medical Oncology's MAP 2018 - Molecular Analysis for Personalised Therapy meeting. During the Innovative clinical trials session, Florent's talk was entitled: 'Immune classification of soft tissue sarcoma and its association with molecular characteristics, and clinical outcome' and was facilitated on 15 September [...]

Rodrigo Dienstmann, VHIO presents COLOSSUS at two scientific meetings

2018-08-23T12:07:07+00:00August 23rd, 2018|

COLOSSUS PI Prof Rodrigo Dienstmann, MD of Vall d'Hebron Institute of Oncology, Barcelona (VHIO) presented COLOSSUS findings at two scientific meetings earlier this year. The first, titled "Molecular subtypes of Colorectal Cancer: tumor and microenvironment interactions" was delivered at a Symphogen scientific event in Denmark on 19 March 2018. Symphogen is a clinical-stage antibody oncology-focused company [...]

COLOSSUS Newsletter for Summer 2018

2018-07-23T12:23:46+00:00July 23rd, 2018|

The COLOSSUS Newsletter for Summer 2018 has just been issued! Download the Newsletter for details of the Project in a nutshell, the story so far and the partners behind the project. Find out about the presentations already made by the team and about future plans. We look forward to bringing you updates on our work [...]

COLOSSUS PhD position available at University College Dublin

2018-06-26T09:38:40+00:00June 26th, 2018|

Our partners at Systems Biology Ireland at UCD are looking for a highly motivated, passionate PhD candidate with the ability to independently plan and conduct the research project while integrating into an interdisciplinary research environment and interested in working with patient advocates. Under the supervision of Dr David Gómez Matallanas, the candidate will investigate the molecular [...]

EuropaColon publishes interview with COLOSSUS Coordinator Annette Byrne

2018-06-11T16:24:50+00:00June 11th, 2018|

On June 11, 2018, EuropaColon published an interview with COLOSSUS Coordinator Prof Annette Byrne. The interview appears in the Latest News section of their website. EuropaColon is an organisation that aims to unite patients, caregivers, healthcare professionals, politicians, the media and the public in the fight against digestive cancers. The Organisation works with 43 groups in 32 European [...]

COLOSSUS precursor project Angiopredict publishes critical biomarker study

2018-06-01T12:52:52+00:00June 1st, 2018|

Researchers from the Framework Programme 7 Angiopredict project (completed) have just achieved a publication in the 24 May 2018 edition of the prestigious international cancer journal Journal of Clinical Oncology (Impact Factor 24). Several of the organisations and researchers involved in Angiopredict are now involved in the COLOSSUS project, which in many ways carries on the [...]